Pico Rivera, California Clinical Trials

A listing of Pico Rivera, California clinical trials actively recruiting patient volunteers.

Filter By
Clear all Advanced
I am/have/had
added new label for I am/have/had
more
I am looking for
added new label for I am looking for
more
Advanced Filters
Found 42 clinical trials
Study to Assess Disease Activity and Biomarkers in Minority Participants With Relapsing Multiple Sclerosis (RMS) Before and During Treatment With Ocrelizumab

This is an open-label, multicenter study that includes a main study for all participants enrolled and an optional cerebrospinal fluid (CSF) sub-study. Self-identified African American (AA) and Hispanic or Latin American (HA) participants with a diagnosis of relapsing multiple sclerosis (RMS) will be enrolled. The treating neurologist must make an …

USC Keck School Of Medicine
 (8.0 away) Contact site
  • 0 views
  • 19 Feb, 2024
  • +30 other locations
Inhalation of KELEA Excellerated Water in Covid-19 Infected Individuals

Preliminary reports have been received from several sources that the periodic inhaling of water with a heightened level of kinetic activity has lessened the severity of symptoms in Covid-19 infected patients. On at least several occasions, a repeat PCR test performed two days after inhaling a particular water-based product was …

Institute of Progressive Medicine
 (9.7 away) Contact site
  • 0 views
  • 19 Feb, 2024
  • 1 location
Study of a Pneumococcal Conjugate Vaccine When Administered Concomitantly With Routine Pediatric Vaccines in Healthy Toddlers and Infants  

Primary Objective: To assess the safety profile of each SP0202 formulation and Prevnar 13 in toddlers and infants (after each and any injection). To assess the immune response (serotype specific IgG concentration) of the SP0202 formulations and Prevnar 13 1 month after the administration of one dose in toddlers (Groups …

Investigational Site Number 8400040
 (7.1 away)
  • 0 views
  • 19 Feb, 2024
  • +31 other locations
None

University of Southern California
 (8.0 away) Contact site
  • 0 views
  • 19 May, 2025
  • +19 other locations
A Study of Lasmiditan (LY573144) Treatment in Children Aged 6 to 17 With Migraine

The reason for this study is to see if lasmiditan is safe and effective in children aged 6 to 17 with migraine. The study will last up to 20 weeks and may include up to 4 visits.

treatment regimen
lasmiditan
migraine
ly573144
preventive medication
Core Healthcare Group
 (7.9 away) Contact site
  • 0 views
  • 19 Feb, 2024
  • +162 other locations
None

University of Southern California
 (8.0 away) Contact site
  • 0 views
  • 19 May, 2025
  • +12 other locations
None

University of Southern California
 (8.0 away) Contact site
  • 0 views
  • 19 May, 2025
  • +13 other locations
Study to Evaluate Safety, Efficacy and Immunogenicity of Acne mRNA Vaccine in Adults With Moderate to Severe Acne

The purpose of the trial is to evaluate the safety, efficacy and immunogenicity of up to 3 intramuscular injections of the Acne mRNA vaccine candidate at up to three dose levels in adult participants aged 18 to 45 years with moderate to severe acne. This trial will consist of a …

Core Healthcare Group- Site Number : 8400067
 (7.9 away) Contact site
  • 0 views
  • 29 Nov, 2025
  • +30 other locations
A Safety Study of Oral Venetoclax in Combination With Intravenous Pembrolizumab in Adult Participants With Previously Untreated Non-Small Cell Lung Cancer (NSCLC) With High Programmed Cell Death Ligand-1 (PD-L1) Expression

Non-Small Cell Lung Cancer (NSCLC) is a solid tumor, a disease in which cancer cells form in the tissues of the lung. It is the most common form of lung cancer, accounting for around 85% of lung cancers. The purpose of this study is to evaluate the safety and efficacy …

pd-l1
erbb1
drug test
solid tumor
growth factor
Icri /Id# 217071
 (6.5 away) Contact site
  • 0 views
  • 19 Feb, 2024
  • +38 other locations
Adenosine Receptor Antagonist Combination Therapy for Metastatic Castrate Resistant Prostate Cancer

This is a Phase 1b/2, open-label, multicenter platform trial to evaluate the antitumor activity and safety of AB928-based combination therapy in participants with metastatic castrate resistant prostate cancer (mCRPC).

combination therapy
testosterone
antiandrogens
antiandrogen therapy
taxane
The Oncology Institute of Hope & Innovation
 (6.5 away) Contact site
  • 0 views
  • 19 Feb, 2024
  • +21 other locations